SignalXSignalX

SI-BONE, Inc. (SIBN) 8-K Current Report: February 23, 2026

Filed: February 23, 2026
Health Care
Surgical & Medical Instruments & Apparatus
SI-BONE, Inc. Overview

SI-BONE, Inc. (SIBN) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
3 items

  • Item 1.01: Entry into a Material Definitive Agreement
  • Item 2.02: Results of Operations and Financial Condition
  • Item 5.02: Departure/Election of Directors or Officers

SI-BONE, Inc. 8-K Feb 23, 2026 Event Analysis

Item 1.01 · Entry into a Material Definitive Agreement

  • • New 102-month HQ lease at 88 W. Plumeria Dr., San Jose — ~50,485 sq ft, commencing no later than Oct 1, 2026
  • • Monthly base rent starts at $128,737 (~$1.54M/year), escalating ~3% annually over the lease term
  • • 6-month rent abatement offsets near-term cash outlay; tenant improvement allowance of $70/sq ft (~$3.5M) plus $5/sq ft (~$252K) for power upgrades
  • • Option to expand by ~28,531 contiguous sq ft if available, plus one 5-year renewal option — signals growth optionality
  • • Security deposit of $163,067 required; total lease commitment spans ~8.5 years, representing a long-term fixed obligation

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 earnings released Feb 23, 2026 — full results in Exhibit 99.1
  • • SIBN reports on minimally invasive sacropelvic procedures; results cover period ended Dec 31, 2025

Item 5.02 · Departure/Election of Directors or Officers

  • • CFO Anshul Maheshwari, age 46, adds COO title effective Feb 22, 2026 — dual role consolidation, no new hire
  • • Move signals cost discipline or streamlining of executive structure rather than external COO search
  • • Maheshwari has held CFO role since April 2021; prior experience at Varian Medical Systems and Bechtel Corp
  • • No additional compensation terms disclosed — watch for proxy or amended filing for any pay changes tied to expanded role

Get deeper insights on SI-BONE, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.